
Experts seek affordable access to medicines for treating Spinal Muscular Atrophy
Seeking urgent Union government intervention to overcome the lack of affordable access to medicines for treating Spinal Muscular Atrophy (SMA) and the need to allow local manufacturers to make the generic version of the drugs to cut down costs Haris Beeran, Rajya Sabha member has written to the Health Ministry.   In India, SMA is classified…